tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

IMMX Stock Latest News

Immix Biopharma initiated with an Outperform at Mizuho
The FlyImmix Biopharma initiated with an Outperform at Mizuho
8d ago
IMMX
Immix Biopharma receives FDA breakthrough therapy designation for NXC-201
PremiumThe Fly
Immix Biopharma receives FDA breakthrough therapy designation for NXC-201
20d ago
IMMX
Immix Biopharma files $750M mixed securities shelf
PremiumThe Fly
Immix Biopharma files $750M mixed securities shelf
1M ago
IMMX
Immix Biopharma price target raised to $12 from $8 at H.C. Wainwright
PremiumThe Fly
Immix Biopharma price target raised to $12 from $8 at H.C. Wainwright
2M ago
IMMX
Immix Biopharma Enters Underwriting Agreement with Morgan Stanley
PremiumCompany Announcements
Immix Biopharma Enters Underwriting Agreement with Morgan Stanley
2M ago
8K
IMMX
Immix Biopharma Announces Positive Phase 2 Trial Results
PremiumCompany AnnouncementsImmix Biopharma Announces Positive Phase 2 Trial Results
2M ago
8K
IMMX
Immix Biopharma 19.12M share Spot Secondary priced at $5.10
Premium
The Fly
Immix Biopharma 19.12M share Spot Secondary priced at $5.10
2M ago
IMMX
Immix Biopharma announces phase 2 NXC-201 results
Premium
The Fly
Immix Biopharma announces phase 2 NXC-201 results
2M ago
IMMX
Immix Biopharma Updates Accounting Firm Consents
PremiumCompany Announcements
Immix Biopharma Updates Accounting Firm Consents
3M ago
8K
IMMX
Immix Biopharma appoints Grabow as Chief Commercial Officer
PremiumThe Fly
Immix Biopharma appoints Grabow as Chief Commercial Officer
3M ago
IMMX
Immix Biopharma: Promising Trial Results and Strong Financial Position Justify Buy Rating
PremiumRatings
Immix Biopharma: Promising Trial Results and Strong Financial Position Justify Buy Rating
3M ago
IMMX
Immix Biopharma’s NXC-201 CAR-T Study: A Potential Game-Changer for AL Amyloidosis
PremiumCompany Announcements
Immix Biopharma’s NXC-201 CAR-T Study: A Potential Game-Changer for AL Amyloidosis
4M ago
IMMX
Immix Biopharma files to sell 6.85M shares of common stock for holders
PremiumThe FlyImmix Biopharma files to sell 6.85M shares of common stock for holders
4M ago
IMMX
Immix Biopharma price target raised to $8 from $7 at H.C. Wainwright
Premium
The Fly
Immix Biopharma price target raised to $8 from $7 at H.C. Wainwright
5M ago
IMMX
Immix Biopharma appoints Nancy Chang to board of directors
Premium
The Fly
Immix Biopharma appoints Nancy Chang to board of directors
5M ago
IMMX
Immix Biopharma Completes Private Placement Transaction
PremiumCompany Announcements
Immix Biopharma Completes Private Placement Transaction
5M ago
8K
IMMX
Immix Biopharma receives strategic investment from Goose Capital
PremiumThe Fly
Immix Biopharma receives strategic investment from Goose Capital
5M ago
IMMX
Immix Biopharma announces ‘class-leading’ safety profile for NXC-201
PremiumThe Fly
Immix Biopharma announces ‘class-leading’ safety profile for NXC-201
7M ago
IMMX
Immix Biopharma’s Strategic Expansion and Promising Trial Results Reinforce Buy Rating
PremiumRatings
Immix Biopharma’s Strategic Expansion and Promising Trial Results Reinforce Buy Rating
7M ago
IMMX
Immix Biopharma announces accelerated NEXICART-2 trial progress
PremiumThe FlyImmix Biopharma announces accelerated NEXICART-2 trial progress
8M ago
IMMX
Immix Biopharma Holds Annual Meeting, Elects Directors
Premium
Company Announcements
Immix Biopharma Holds Annual Meeting, Elects Directors
8M ago
8K
IMMX
Promising Interim Results from NEXICART-2 Trial Support Buy Rating for NXC-201
Premium
Ratings
Promising Interim Results from NEXICART-2 Trial Support Buy Rating for NXC-201
9M ago
IMMX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >